Association of Premenopausal Bilateral Oophorectomy With Restless Legs Syndrome.


Journal

JAMA network open
ISSN: 2574-3805
Titre abrégé: JAMA Netw Open
Pays: United States
ID NLM: 101729235

Informations de publication

Date de publication:
01 02 2021
Historique:
entrez: 1 2 2021
pubmed: 2 2 2021
medline: 13 4 2021
Statut: epublish

Résumé

Restless legs syndrome is a common neurologic disorder that is more prevalent in women than in men, and it has been suggested that female hormones may be involved in the disorder's pathophysiology. To determine whether women who underwent premenopausal bilateral oophorectomy were at increased risk of restless legs syndrome. This cohort study was performed using data from the Mayo Clinic Cohort Study of Oophorectomy and Aging-2 for a population in Olmsted County, Minnesota. There were 1653 women who underwent premenopausal bilateral oophorectomy before the age of 50 years for a benign indication between 1988 and 2007 and 1653 age-matched women (of same age plus or minus 1 year) in a reference group. Follow-up was conducted until the end of the study period (ie, December 31, 2014). Data were analyzed from January to July 2020. Undergoing bilateral oophorectomy, as shown in medical record documentation. Diagnosis of restless legs syndrome, as defined using Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition) criteria, was recorded. Among 3306 women, the median (interquartile range) age at baseline was 44.0 (40.0-47.0) years. Women who underwent bilateral oophorectomy, compared with women who did not undergo this procedure, had a greater number of chronic conditions at the index date (eg, 300 women [18.1%] vs 171 women [10.3%] with ≥3 chronic conditions; overall P < .001), were more likely to have obesity (576 women [34.8%] vs 442 women [27.1%]; overall P < .001), and were more likely to have a history of anemia of any type (573 women [34.7%] vs 225 women [13.6%]; P < .001), iron deficiency anemia (347 women [21.0%] vs 135 women [8.2%]; P < .001), and restless legs syndrome before the index date (32 women [1.9%] vs 14 women [0.8%]; P = .008). Women who underwent bilateral oophorectomy prior to natural menopause had a higher risk of restless legs syndrome after the index date compared with women in the reference group (120 diagnoses vs 74 diagnoses), with an adjusted hazard ratio (HR) of 1.44 (95% CI, 1.08-1.92; P = .01). After stratification by indication for the bilateral oophorectomy, there was an increased risk of restless legs syndrome among women without a benign ovarian condition (HR, 1.52; 95% CI, 1.03-2.25; P = .04) but not among women with a benign condition (HR, 1.25; 95% CI, 0.80-1.96; P = .34). Treatment with estrogen therapy through the age of 46 years in women who underwent bilateral oophorectomy at younger ages was not associated with a difference in risk. This cohort study found that risk of restless legs syndrome was increased among women who underwent bilateral oophorectomy prior to menopause, especially those without a benign ovarian indication.

Identifiants

pubmed: 33523190
pii: 2775661
doi: 10.1001/jamanetworkopen.2020.36058
pmc: PMC7851733
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2036058

Subventions

Organisme : NIA NIH HHS
ID : R33 AG058738
Pays : United States
Organisme : NIA NIH HHS
ID : U54 AG044170
Pays : United States

Références

Arch Intern Med. 2004 Jan 26;164(2):196-202
pubmed: 14744844
Sleep Med Rev. 2018 Apr;38:28-38
pubmed: 28495359
Sleep Med. 2003 Mar;4(2):101-19
pubmed: 14592341
Mayo Clin Proc. 2012 Dec;87(12):1202-13
pubmed: 23199802
Neurology. 2014 Jun 3;82(22):2026-33
pubmed: 24808014
Mol Cell Neurosci. 2004 Dec;27(4):466-76
pubmed: 15555924
Mayo Clin Proc. 2012 Feb;87(2):151-60
pubmed: 22305027
Mov Disord. 2001 Nov;16(6):1159-63
pubmed: 11748753
Prog Neuropsychopharmacol Biol Psychiatry. 2007 Jun 30;31(5):1078-83
pubmed: 17459547
JAMA Neurol. 2019 Jan 1;76(1):95-100
pubmed: 30326011
JAMA. 2017 Feb 21;317(7):780
pubmed: 28241358
Neurology. 2016 Apr 5;86(14):1336-1343
pubmed: 26944272
Calcif Tissue Int. 1986 Sep;39(3):139-44
pubmed: 3093024
Eur Neurol. 2001;46(1):17-9
pubmed: 11455178
Am J Epidemiol. 2011 May 1;173(9):1059-68
pubmed: 21430193
J Psychosom Res. 2002 Jul;53(1):547-54
pubmed: 12127170
BMJ Open. 2017 Nov 20;7(11):e018861
pubmed: 29162577
Arch Intern Med. 2005 Jun 13;165(11):1286-92
pubmed: 15956009
Sleep Med Rev. 2012 Aug;16(4):283-95
pubmed: 21795081
Obstet Gynecol. 2010 Nov;116(5):1088-95
pubmed: 20966693
Semin Neurol. 2017 Dec;37(6):653-660
pubmed: 29270938
Acta Neurol Scand. 2016 May;133(5):320-9
pubmed: 26482928
Ann Pharmacother. 2018 Jul;52(7):662-672
pubmed: 29482354
Mayo Clin Proc. 2016 Nov;91(11):1577-1589
pubmed: 27693001
J Gerontol A Biol Sci Med Sci. 2017 Sep 1;72(9):1213-1217
pubmed: 28329133
Neuropharmacology. 2001 May;40(6):761-71
pubmed: 11369030
Neurodegener Dis. 2012;10(1-4):175-8
pubmed: 22269187
Prev Chronic Dis. 2013 Apr 25;10:E66
pubmed: 23618546
J Clin Sleep Med. 2012 Apr 15;8(2):119-24
pubmed: 22505854
Sleep Med Rev. 2018 Aug;40:43-54
pubmed: 29169861
Int J Epidemiol. 2012 Dec;41(6):1614-24
pubmed: 23159830
Proc Natl Acad Sci U S A. 2016 Aug 16;113(33):9327-32
pubmed: 27457926
Am J Obstet Gynecol. 2008 Jan;198(1):34.e1-7
pubmed: 17981254
J Neurol. 2007 Dec;254(12):1748-9
pubmed: 17990060
Genome Biol. 2013;14(10):R115
pubmed: 24138928
JAMA Intern Med. 2013 Apr 8;173(7):496-505
pubmed: 23460396
Sleep Med Rev. 2012 Aug;16(4):297-307
pubmed: 22075215
Neurology. 2008 Jan 15;70(3):200-9
pubmed: 17761549
Eur J Pharmacol. 2005 Mar 28;511(2-3):121-6
pubmed: 15792779
J Neurosci. 2000 Dec 1;20(23):8604-9
pubmed: 11102464
Neurology. 2007 Sep 11;69(11):1074-83
pubmed: 17761551
Mol Cell Endocrinol. 2014 May 25;389(1-2):7-12
pubmed: 24508665

Auteurs

Nan Huo (N)

Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.

Carin Y Smith (CY)

Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.

Liliana Gazzuola Rocca (L)

Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.

Walter A Rocca (WA)

Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Department of Neurology, Mayo Clinic, Rochester, Minnesota.
Mayo Clinic Specialized Research Center of Excellence on Sex Differences, Mayo Clinic, Rochester, Minnesota.

Michelle M Mielke (MM)

Division of Epidemiology, Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Department of Neurology, Mayo Clinic, Rochester, Minnesota.
Mayo Clinic Specialized Research Center of Excellence on Sex Differences, Mayo Clinic, Rochester, Minnesota.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH